Highlights

• There was a growing trend in childhood prediabetes prevalence worldwide with time and BMI.
• Higher prevalence was observed for males than females, older than younger children, urban than rural areas, and children with family histories of diabetes than those without such a history.

Highlights

Neutrophil count was an independent risk factor for CKD in patients with diabetes, especially when it exceeded 3.6 × 10⁹/L, and increased neutrophil count could predict progression of CKD in patients with diabetes.

Highlights

• The Acarbose Cardiovascular Evaluation (ACE) trial assessed the effects of acarbose in patients with coronary heart disease (CHD) and impaired glucose tolerance (IGT) in China.
• Acarbose treatment did not impact on health-related quality of life in ACE trial participants with CHD and IGT.
• Myocardial infarction (MI), stroke, heart failure, and angina were found to reduce health-related quality of life around the time they occurred; only MI and stroke may impact on longer-term health-related quality of life.

Highlights

• Our study retrospectively analyzed 46 979 members of the noninstitutionalized US population and found that anthropometric parameters, including weight, body mass index, waist circumference (WC), waist-to-height ratio (WtHR), A Body Shape Index, and conicity index (CI), had a significant positive correlation with diabetes.
• CI, a novel central-obesity index based on WC, weight, and height, showed the strongest discriminatory power among these six indices.
• WtHR is the second-best anthropometric index after CI; with the advantages of being robust and straightforward, WtHR may be a good alternative for identifying diabetes.

Highlights

• The accordance between the paired dataset between FSL and iPro2 was acceptable but poorer in hypoglycemic range.
• Significant differences for glycemic metrics between iPro2 and FSL were observed in time in range 70–180 mg/dL, coefficient of variation, and hypoglycemia-related parameters (including time below range 54 mg/dL and 70mg/dL).
• The study reminded us when using the CGM for clinical decisions and clinical trials, it is necessary to consider the model heterogeneity.